Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scIgG)  (SCIGG-158)

Recombinant Anti-EGFR x Anti-ZnO Bispecific Antibody (scIgG) is designed to be expressed as two chains, each chain has the same units with their parental IgG antibodies, anti-EGFR and anti-ZnO IgGs. The two chains form heterodimer via Fc KIH technology. This BsAb can be used in immunoassay of Head and neck cancer; Non-small cell lung cancer (NSCLC); Gastric cancer; Lung cancer; Colorectal cancer (CRC); Solid tumors.

Datasheet